Onconetix

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$2.45-$552.50
Market Cap
$5.9M
Shares Short
51,072

Financials

See more
Revenue (12 Mos)
$1.3M
Revenue Growth (YoY)
-84.9%
Gross Profit (12 Mos)
$881,717
Diluted EPS
$2,044.06

News

See more

Yahoo Finance • 13 days ago

Onconetix announces financing through private placement, debt settlement

Yahoo Finance • 14 days ago

Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.

Yahoo Finance • 14 days ago

Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement

Yahoo Finance • 18 days ago

Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM

About

CEO
Ms. Karina M. Fedasz
CFO
Ms. Karina M. Fedasz
Address
201 East Fifth Street, Cincinnati, OH, United States, 45202
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
5